Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is ongoing in the Netherlands. It is testing open label study with objective sleepregistration on the effects of Doxazosin as treatment for PTSD.
In Netherlands
This summary needs review. Please check the official study record and contact the research team for details.
In Belmont
This study exists to understand whether the medication TMS is both safe enough and useful enough to take further. Researchers are trying to understand whether the medication TMS can give earlier or clearer feedback during care.
Multiple locations, including BaltimoreThis study is completed in Germany, in Spain, and in Portugal. It is testing Long Term Safety of Prolonged Release (PR) OROS Methylphenidate (18, 36, 54, 72 and 90 mg/day) for ADHD.
In GermanyThis study is ongoing in France, in Belgium, in Czechia, .... It focuses on schizophrenia.
In FranceThis summary needs review. Please check the official study record and contact the research team for details.
In ChibaThis study exists to explore whether the medication Tipepidine could improve care and understanding. Researchers are trying to understand whether the medication Tipepidine can improve attention, thinking, or day-to-day functioning.
In ChibaThis summary needs review. Please check the official study record and contact the research team for details.
Location not clearly listedThis summary needs review. Please check the official study record and contact the research team for details.
In Augusta
This study is completed in the United Kingdom, in the Netherlands, in Czechia, .... It focuses on PTSD.
In NetherlandsThis study is completed in Australia. It is testing lamotrigine for Bipolarity.
Multiple locations, including GreenwichThis study is completed in Latvia, in Bulgaria, and in Croatia. It is testing SEP-363856 for schizophrenia.
In LatviaHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.